ARKG

ARK Genomic Revolution ETF

$30.67

+0.14 (+0.46%)

AUM $1.24B

Expense Ratio 0.75%

NAV $30.67

Holdings 10

Asset Class Equity

Inception 10/30/2014

Provider ARK

Top Holdings

1 TWST TWIST BIOSCIENCE CORP 8.53% 2 CRSP CRISPR THERAPEUTICS AG 8.28% 3 TEM TEMPUS AI INC-CL A 8.02% 4 TXG 10X GENOMICS INC-CLASS A 6.21% 5 PSNL PERSONALIS INC 5.25% 6 BEAM BEAM THERAPEUTICS INC 4.83% 7 ABSI ABSCI CORP 4.81% 8 GH GUARDANT HEALTH INC 4.65% 9 ILMN ILLUMINA INC 4.51% 10 NTRA NATERA INC 4.25%

Fund Description

ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.